Invention Grant
- Patent Title: c-Met antibodies
- Patent Title (中): c-Met抗体
-
Application No.: US13531858Application Date: 2012-06-25
-
Publication No.: US08398974B2Publication Date: 2013-03-19
- Inventor: Julian Davies , Ling Liu , Jirong Lu , Peter Edward Vaillancourt , Mark Andrew Wortinger , Wei Zeng
- Applicant: Julian Davies , Ling Liu , Jirong Lu , Peter Edward Vaillancourt , Mark Andrew Wortinger , Wei Zeng
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Robert L. Sharp
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
Provided are monoclonal antibodies, antigen-binding fragments thereof, and combinations of the foregoing, that bind to, and inhibit the activity of, c-Met, and that are effective in treating cancers and other diseases, disorders, or conditions where pathogenesis is mediated by c-Met.
Public/Granted literature
- US20120263723A1 c-Met Antibodies Public/Granted day:2012-10-18
Information query
